Search | Clinical Trials Finder

Independent directory Public ClinicalTrials.gov records United States

ClinicalTrials.gov public records Last synced Jul 22, 2026, 8:19 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–48 of 24 matching trials from the live ClinicalTrials.gov search.

Local D1 index available.

Filters: Condition: Ovarian Cysts Clear all

Conditions: Obstructive Sleep Apnea Syndrome, Polycystic Ovary Syndrome, Sleep Apnea
Interventions: Nasal Continuous positive airway pressure (CPAP); Device
Lead sponsor: Albert Einstein College of Medicine; Other
Eligibility: 13 Years to 21 Years · Female only
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Polycystic Ovary Syndrome, Insulin Resistance
Interventions: Vigorous Exercise, Moderate Exercise; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 47 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2025
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Polycystic Ovary Syndrome
Interventions: No intervention; Other
Lead sponsor: David Grant U.S. Air Force Medical Center; Federal
Eligibility: 18 Years and older · Female only
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Travis Air Force Base, California

Conditions: Polycystic Ovary Syndrome
Interventions: Etonogestrel/ethinyl estradiol vaginal ring; Drug
Lead sponsor: Andrea Roe, MD, MPH; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Polycystic Ovary Syndrome
Interventions: Not listed
Lead sponsor: PCOS Challenge: The National Polycystic Ovary Syndrome Association; Other
Eligibility: 12 Years to 80 Years · Female only
Enrollment: 15,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2042
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Sleep Apnea, Obstructive, Anovulation, Polycystic Ovarian Syndrome
Interventions: CPAP; Device
Lead sponsor: University of Louisville; Other
Eligibility: 18 Years to 35 Years · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Polycystic Ovary Syndrome (PCOS)
Interventions: REPS w/BANDS; Behavioral
Lead sponsor: University of South Carolina; Other
Eligibility: 18 Years and older · Female only
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Columbia, South Carolina

Conditions: Polycystic Ovary Syndrome
Interventions: metformin, exenatide or combined (metformin & exenatide ); Drug
Lead sponsor: Metabolic Center of Louisiana Research Foundation; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Hyperandrogenemia, Polycystic Ovary Syndrome
Interventions: Progesterone, Estrace (estrogen); Drug
Lead sponsor: University of Virginia; Other
Eligibility: 8 Years to 14 Years · Female only
Enrollment: 3 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Polycystic Ovarian Syndrome, Obesity, Hepatic Steatosis
Interventions: oral glucose tolerance test, MRI of liver; Diagnostic Test
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 12 Years to 21 Years · Female only
Enrollment: 19 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Polycystic Ovary Syndrome, Insulin Resistance
Interventions: Cinnamon Supplementation, Placebo (wheat flour); Dietary Supplement
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 20 Years to 40 Years · Female only
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Polycystic Ovary Syndrome
Interventions: Flutamide, Placebo; Drug
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 72 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2024
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Polycystic Ovary Syndrome
Interventions: pioglitazone, metformin, placebo; Drug
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 37 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2011
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Polycystic Ovary Syndrome
Interventions: Sitagliptin, Placebo; Drug
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Polycystic Ovary Syndrome, Non-Alcoholic Fatty Liver Disease, Metabolic Syndrome
Interventions: Metformin, Placebo; Drug
Lead sponsor: Columbia University; Other
Eligibility: 13 Years to 25 Years · Female only
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Polycystic Ovary Syndrome
Interventions: pioglitazone, Placebo; Drug
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Polycystic Ovary Syndrome, PCOS, Insulin Sensitivity
Interventions: placebo, metformin; Drug
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2010
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Benign Cysts Ovarian, Cystectomy, Torsion, Malignant Cysts Ovarian
Interventions: Not listed
Lead sponsor: Ann & Robert H Lurie Children's Hospital of Chicago; Other
Eligibility: Up to 18 Years · Female only
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2030
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Epithelial Ovarian Cancer
Interventions: Mirena® intra-uterine device (IUD); Device
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 35 Years to 50 Years · Female only
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2022
U.S. locations: 6
States / cities: Basking Ridge, New Jersey • Middletown, New Jersey • Commack, New York + 3 more

Conditions: Polycystic Ovary Syndrome
Interventions: rosiglitazone, drospirenone/ethinyl estradiol; Drug
Lead sponsor: Silva Arslanian; Other
Eligibility: 10 Years to 20 Years · Female only
Enrollment: 65 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2015
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Polycystic Ovary Syndrome
Interventions: Not listed
Lead sponsor: National Institute of Environmental Health Sciences (NIEHS); NIH
Eligibility: 18 Years and older · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Polycystic Ovarian Syndrome (PCOS), Patients Sensitive to Exogenous Gonadotropins, Ovarian Hyper Stimulation Syndrome (OHSS)
Interventions: In Vitro maturation; Biological
Lead sponsor: Northwell Health; Other
Eligibility: 25 Years to 42 Years · Female only
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Manhasset, New York

Conditions: Polycystic Ovary Syndrome
Interventions: Nutropin; Drug
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 21 Years to 45 Years · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Polycystic Ovary Syndrome
Interventions: Inositol supplement, Placebo supplement; Dietary Supplement
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 36 Years
Enrollment: 168 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma